Rheumatologists use different cut offs for disease activity in real life - the experience with Golimumab in ankylosing spondylitis – Subanalysis from the Non-Interventional German GO-NICE study - Braun, J; Baraliakos, X; Kiltz, U (J Rheumatol, 2019)
et al.